3rd Quarter - Report
SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
ADHD awareness; R&D funding for rare disease products, biosimilars and other products; Life Sciences Investment Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOFF MASUKAWA | — |
Pharmacy PHA
Life Sciences Investment Act; orphan drugs; end stage renal disease (ESRD) bundling of non-injectable oral equivalents; ESRD Quality Incentive program; Prescription Drug User Fee program; reimbursements; drug shortages; DEA quotas
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOFF MASUKAWA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.